27 July 2020 ORYZON presents vafidemstat clinical data from its Phase IIa clinical trial ETHERAL in Alzheimer’s at the virtual AAIC-2020 conference
6 July 2020 ORYZON presents final data from its Phase IIa clinical trial REIMAGINE at the 28th European Congress of Psychiatry, EPA 2020
19 June 2020 ORYZON enters into pioneering precision medicine collaboration with La Paz Hospital in Madrid for Phelan-McDermid Syndrome
15 June 2020 ORYZON initiates a new project to explore the efficacy of vafidemstat in the treatment of schizophrenia
2 June 2020 ORYZON to present additional efficacy clinical data from ALICE Phase IIa trial with iadademstat at the 25th Congress of the European Hematology Association
1 June 2020 ORYZON publishes characterization and mechanism of action of vafidemstat, a Phase II clinical stage LSD1 inhibitor, in PLOS ONE